Treatment of diabetes mellitus with amylin agonists

Garth Cooper (Other)

    Research output: Patent


    Novel methods for treating diabetes mellitus and hyperglycemia are described which comprise administering to a diabetic or hypoglycemic subject an amount of an amylin agonist effective to induce amylin activity in said subject. Various amylin agonist compounds, and therapeutic methods utilizing such compounds, are also disclosed.
    Original languageEnglish
    Patent number5175145
    Publication statusPublished - 29 Dec 1992


    Dive into the research topics of 'Treatment of diabetes mellitus with amylin agonists'. Together they form a unique fingerprint.

    Cite this